#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10234	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2161	464.9	1	SNP	n	C1184T	0	.	.	1184	1184	C	1523	1523	C	579	C,G	550,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10234	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2161	464.9	0	HET	.	.	.	C207T	.	207	207	C	546	546	C	554	C,T	423,108	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	10234	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2161	464.9	0	HET	.	.	.	C451T	.	451	451	C	790	790	C	561	C,T	307,232	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	490.6	0	.	n	.	0	T695C	SNP	695	695	T	1046	1046	C	514	C	501	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	490.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2322	2322	C	558	C,T	527,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	490.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2396	2396	A	564	A	555	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	490.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2948	2948	C	509	C	496	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	17998	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3622	490.6	0	HET	.	.	.	A1638G	.	1638	1638	A	1989	1989	A	551	A,G	283,249	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	1178	folP	855	855	100.0	folP.l15.c4.ctg.1	1536	75.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1024	1026	AGC	127;128;128	A,C;G;C	123,3;127;125	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3286	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3558	91.1	1	SNP	p	S91F	1	.	.	271	273	TTC	600	602	TTC	103;103;104	T;T;C	98;98;99	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3286	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3558	91.1	1	SNP	p	D95G	1	.	.	283	285	GGC	612	614	GGC	104;105;102	G;G,A;C,G	98;100,1;97,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	3286	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3558	91.1	1	SNP	p	G95N	0	.	.	283	285	GGC	612	614	GGC	104;105;102	G;G,A;C,G	98;100,1;97,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1030	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1281	78.9	1	SNP	p	G45D	0	.	.	133	135	GGC	409	411	GGC	126;123;123	G;G,A;C	124;118,2;119	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	540	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1075	50.2	0	.	n	.	0	A197.	DEL	197	197	A	612	612	A	122	A	119	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3280	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	109.9	1	SNP	p	D86N	0	.	.	256	258	GAC	548	550	GAC	134;136;138	G;A;C,A	131;130;134,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3280	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	109.9	1	SNP	p	R87W	0	.	.	259	261	CGT	551	553	CGT	139;140;138	C,A;G;T	136,1;136;135	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3280	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	109.9	1	SNP	p	R87I	0	.	.	259	261	CGT	551	553	CGT	139;140;138	C,A;G;T	136,1;136;135	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3280	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	109.9	1	SNP	p	S87R	1	.	.	259	261	CGT	551	553	CGT	139;140;138	C,A;G;T	136,1;136;135	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	3280	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2935	109.9	1	SNP	p	S88P	0	.	.	262	264	TCC	554	556	TCC	139;141;141	T;C;C	135;136;137	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2396	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2661	88.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1507	1509	GGC	117;115;114	G;G;C	114;112;111	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1250	1252	GCC	136;137;137	G,C;C;C	129,1;132;131	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1253	1255	ATG	139;141;140	A;T;G	130;135;134	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1265	1267	ACC	143;143;146	A;C;C	137;140;139	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1265	1267	ACC	143;143;146	A;C;C	137;140;139	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1766	1768	ACC	110;111;109	A;C;C	101;105;103	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1820	1822	GCG	106;104;106	G;C;G	104;101;102	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1820	1822	GCG	106;104;106	G;C;G	104;101;102	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1943	1945	GGT	99;99;100	G;G;T,C	95;96;92,1	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1952	1954	AGC	97;96;97	A,G;G;C	92,1;93;91	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	2524	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2459	100.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1970	1972	CCG	76;77;78	C,G;C,G;G,C	68,3;69,1;69,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	3762	ponA	2397	2397	100.0	ponA.l6.c4.ctg.1	3156	117.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1702	1704	CCG	139;140;139	C;C;G,C	129;133;128,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1606	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1773	88.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	613	613	C	106	C	102	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	198	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	647	12.1	0	.	p	.	0	H217N	NONSYN	649	651	CAT	396	398	AAT	13;13;13	A;A;T	12;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	198	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	647	12.1	0	.	p	.	0	D218N	NONSYN	652	654	GAT	399	401	AAT	13;13;13	A;A;T	13;13;13	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	198	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	647	12.1	0	.	p	.	0	V226A	NONSYN	676	678	GTA	423	425	GCA	12;12;12	G;C;A	12;12;12	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	198	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	647	12.1	0	.	p	.	0	.	MULTIPLE	700	702	ACT	446	448	GTA	9;10;11	G;T;A	9;10;10	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	198	porB1a	984	276	90.71	porB1a.l15.c30.ctg.2	647	12.1	0	.	p	.	0	N237fs	FSHIFT	709	709	A	455	455	A	11	A	11	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1976	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1635	118.7	1	SNP	p	G120K	1	.	.	358	360	AAG	626	628	AAG	158;157;155	A;A;G,C,A	152;152;147,1,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1976	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1635	118.7	1	SNP	p	N121D	0	.	.	361	363	AAC	629	631	AAC	159;158;161	A,G;A;C	152,1;152;153	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	1976	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1635	118.7	1	SNP	p	A121N	1	.	.	361	363	AAC	629	631	AAC	159;158;161	A,G;A;C	152,1;152;153	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	S217G	NONSYN	649	651	AGC	297	299	GGC	14;14;14	G;G;C	14;14;14	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	D222N	NONSYN	664	666	GAT	312	314	AAT	15;15;15	A;A;T	15;15;15	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	V230A	NONSYN	688	690	GTA	336	338	GCA	17;17;17	G;C;A	17;17;17	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	V238Y	NONSYN	712	714	GTT	360	362	TAT	16;17;17	T;A;T	16;16;17	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	.	INDELS	715	717	GAA	364	370	GAGCAAT	17;17;17;17;17;17;16	G;A;G;C;A;A;T	17;17;17;17;17;17;16	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	.	INDELS	719	720	AC	373	375	GCG	20;21;23	G;C;G,A	19;21;22,1	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	L253V	NONSYN	757	759	TTG	414	416	GTA	31;30;29	G;T;A	31;30;29	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	S273T	NONSYN	817	819	TCG	474	476	ACT	44;42;38	A;C;T	40;40;37	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	K278N	NONSYN	832	834	AAA	489	491	AAC	31;32;33	A;A;C	31;32;33	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	R279H	NONSYN	835	837	CGC	492	494	CAC	34;35;36	C;A;C	34;34;36	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	E313A	NONSYN	937	939	GAA	594	596	GCA	35;34;32	G;C;A	31;30;30	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	N314D	NONSYN	940	942	AAC	597	599	GAC	31;27;27	G;A;C	30;26;27	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	F316I	NONSYN	946	948	TTC	603	605	ATC	25;23;21	A;T;C	24;23;19	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	A318S	NONSYN	952	954	GCG	609	611	TCG	16;17;17	T;C;G	16;17;15	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	G321S	NONSYN	961	963	GGC	618	620	AGC	17;16;16	A;G;C	17;15;15	.	.
porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	porB3.Neisseria_meningitidis_serogroup_A_Z2491_v1_00376	1	0	528	232	porB3	990	356	90.14	porB3.l6.c17.ctg.2	786	18.4	0	.	p	.	0	G322A	NONSYN	964	966	GGT	621	623	GCC	16;16;16	G;C;C	16;16;16	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	6650	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	4874	134.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	744	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1054	69.4	1	SNP	p	V57M	1	.	.	169	171	ATG	499	501	ATG	139;138;136	A;T;G	133;133;133	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
